American Healthcare Capital is pleased to introduce a uniquely focused Pharmacy whose main concentration rests in servicing Addiction Rehabilitation Facilities in Southern California. The company has been in business for over 7 years and due to their strategic location and unparalleled service, has positioned themselves as the premier addiction rehabilitation pharmaceutical provider within their geographic area. This California market offers exceptional growth potential. They service patients from California and from many out of state locations who elect to seek their rehabilitation in California. Much of their collections are on a COD basis.
In 2019 they generated $1.9 million in gross revenues and with an adjusted EBITDA of $286,000. Their 2020 revenues are projected to exceed $2,375,000 with an adjusted EBITDA of $375,000.
All key staff are expected to stay on, and the seller will accommodate a transitional period conducive to the buyer’s requirements.
The asking price for this opportunity is $1,700,000.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.